1st Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform S.23 - America Invents Act of 2011 H.R. 1249 - America Invents Act of 2011

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Medicare/Medicaid MMM

H.R. 675 - "To expand the permissive exclusion from participation in federal health care programs to individuals and entities affiliated with sanctioned entities."

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 675 (112th)

Health Issues HCR

Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Judiciary issues related to H.R. 5 - The Health Act. H.R. 1065 - Pill Mill Crackdown Act of 2011. Educated staff about issues concerning the 510(k) device approval process. S. 17 - Medical Device Access and Innovation Act H.R. 436 - Protect Medical Device Innovation Act

LobbyistCovered position, as disclosed
DARREN WILLCOX House Rules Comm Assoc, Subcomm Staff Dir.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1065 (112th), H.R. 5 (112th), H.R. 436 (112th), S. 17 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.